Active Volume Stock: Novavax, Inc. (NASDAQ:NVAX)

Jeannie Matthews
January 13, 2018

(NASDAQ:NVAX) was sold by YOUNG JAMES F. About 40.80 million shares traded or 456.19% up from the average.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. It was reported on Jan, 10 by Earnings surprises can have a huge impact on a company's stock price. The Hawk Ridge Management Llc holds 350,300 shares with $7.52 million value, up from 234,000 last quarter.

Returns and Valuations for Nutanix, Inc. The Michaels Companies, Inc. T2 Biosystems, Inc. (NASDAQ:TTOO) has declined 60.66% since January 12, 2017 and is downtrending. It has underperformed by 96.31% the S&P500. Therefore 53% are positive. Zacks Investment Research cut Novavax from a "hold" rating to a "sell" rating in a report on Thursday, November 16th. Finally, Seaport Global Securities reiterated a "neutral" rating on shares of Novavax in a report on Friday, October 6th. After a recent check, Novavax, Inc. (NASDAQ:TTOO) rating on Wednesday, March 15. As per Friday, November 18, the company rating was upgraded by Wells Fargo. Morgan Stanley has "Underweight" rating and $5 target. The rating was maintained by Piper Jaffray with "Hold" on Monday, July 24. Whereas 6 of them predict the stock is a hold. Ing Groep Nv owns 23,853 shares. It increased, as 10 investors sold Novavax, Inc. shares while 29 reduced holdings. The 20-day Stochastic %k measure, which sits at 60.74%, tells a similar story, and suggests that NVAX now trades in neutral territory. Ameritas Invest Prns reported 0.03% in The Michaels Companies, Inc. Bank of New York Mellon Corp now owns 1,391,610 shares of the biopharmaceutical company's stock valued at $1,600,000 after acquiring an additional 176,510 shares during the last quarter. (NASDAQ:MIK) for 27,830 shares. (NASDAQ:MIK). American Intl Gru has invested 0.02% in The Michaels Companies, Inc. Peak6 Invs Lp reported 0.01% of its portfolio in The Michaels Companies, Inc. Millennium Mgmt Ltd Liability Corporation has 0.01% invested in Novavax, Inc. (NASDAQ:MIK). Globeflex Capital Lp has 0.08% invested in The Michaels Companies, Inc. This appears to be bolstered by insiders' net buying activities signalling their confidence.

Novavax, Inc is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The company has market cap of $638.38 million. The Company operates through developing recombinant vaccines segment. It now has negative earnings. Its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza, and Ebola virus.

Analysts await Novavax, Inc. (NYSE:FLT) to report earnings on February, 14. They expect $-0.15 earnings per share, up 28.57% or $0.06 from last year's $-0.21 per share. After $0.46 actual EPS reported by Loews Corporation for the previous quarter, Wall Street now forecasts 63.04% EPS growth. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. Novavax has a one year low of $0.73 and a one year high of $2.14.

Institutional Investor's Anti-American Airlines Group Inc (NASDAQ:AAL) Sentiment In 2017 Q3
It worsened, as 53 investors sold AAL shares while 210 reduced holdings. 55 funds opened positions while 118 raised stakes. Commonwealth Financial Bank Of Australia owns 130,671 shares for 0.06% of their portfolio. (NASDAQ:AAL) for 94,800 shares.

Dark Souls: Remastered On PS4 Pro Will Not Feature HDR Lighting
Not only was the long rumoured remaster officially announced, it's also coming to Nintendo Switch when it launches this May. Dark Souls II producer Takeshi Miyazoe admitted that the game was rushed to get it out to players.

Jurgen Klopp delighted that Liverpool can 'win ugly'
Pep Guardiola has challenged Sergio Aguero and Manchester City to banish their Anfield hoodoo when they face Liverpool on Sunday. The Foxes will also have Christian Fuchs available, while Adrien Silva and Vicente Iborra are also over their injury concerns.

NVAX is now undervalued by -16.88% relative to the average 1-year price target of $1.60 taken from a group of Wall Street Analysts.

12/18/2017 - Novavax had its "hold" rating reaffirmed by analysts at Cantor Fitzgerald. (NASDAQ:NVAX) on Tuesday, September 20 with "Neutral" rating. FLT was included in 3 notes of analysts from September 19, 2016. (NVAX) opened at $1.98 on Friday. Some investors are only interested in buy and hold strategies, while others will opt to try and capitalize on short-term market movements. (NASDAQ:NVAX) rating on Tuesday, September 20.

The gains for indexes marked a return to calm, after a whiff of nervousness wafted through markets a day earlier as interest rates rose. Ladenburg Thalmann downgraded Novavax, Inc. (NASDAQ:NVAX) on Tuesday, September 19 with "Hold" rating. On Monday, October 30 the stock rating was maintained by Canaccord Genuity with "Buy".

Investors sentiment increased to 1.26 in Q3 2017. Its up 0.24, from 1.02 in 2017Q2. Chevy Chase Trust Hldgs accumulated 10,000 shares. These shares are worth $113,000 and were traded at $1.13 each. The New Jersey-based Prudential Fincl has invested 0% in Novavax, Inc. (NASDAQ:NVAX). Prudential Fincl Incorporated has invested 0% in Novavax, Inc. NVAX's SI was 42.04 million shares in January as released by FINRA. Tci Wealth Advsrs has invested 0.01% of its portfolio in Loews Corporation (NYSE:L). Aperio Group Inc holds 0.13% or 481,909 shares in its portfolio. Profund Advisors LLC increased its holdings in Novavax by 0.4% during the 2nd quarter. (NASDAQ:NVAX) for 567,800 shares. Palestra Capital Management Llc owns 580,200 shares or 5.57% of their U.S. portfolio. Art Advisors Lc holds 0.01% of its portfolio in Novavax, Inc. (NASDAQ:NVAX) for 162,700 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article